Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03289910
Title Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

atypical chronic myeloid leukemia, BCR-ABL1 negative


myelodysplastic/myeloproliferative neoplasm

acute myeloid leukemia

chronic myelomonocytic leukemia

essential thrombocythemia

myeloproliferative neoplasm


Carboplatin + Topotecan + Veliparib

Carboplatin + Topotecan

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.